Drug safety analyses in a rheumatoid arthritis registry: application of different approaches regarding timing of exposure and confounder measurement

BACKGROUND: Patient registry data serves an increasing role in drug safety and comparative effectiveness research, but registry databases often do not contain confounder information measured at the same time that treatments begin. This study evaluated a set of approaches for estimating confounder va...

Descripción completa

Detalles Bibliográficos
Autores principales: Solomon, Daniel H., Shadick, Nancy A., Weinblatt, Michael E., Zak, Agnes, Frits, Michelle, Franklin, Jessica M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5470201/
https://www.ncbi.nlm.nih.gov/pubmed/28610614
http://dx.doi.org/10.1186/s13075-017-1330-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5470201/
https://www.ncbi.nlm.nih.gov/pubmed/28610614
http://dx.doi.org/10.1186/s13075-017-1330-0

Ejemplares similares